Four more EIT Health-supported start-ups gain EIC grants
The start-ups gained Europe-wide exposure through our Catapult programme. They have now received accelerator grants and equity investments from the European Innovation Council (EIC).
This brings the total number of EIT Health Catapult alumni to receive EIC grants in 2022 to seven. The EIC Accelerator offers start-ups and SMEs grants of up to EUR 2.5M combined with EIC Fund equity investments ranging from EUR 500 000 to EUR 15M. In addition to financial support, the start-ups will gain access to leading experts, corporations, investors, and ecosystem actors who can help their businesses grow. Learn more about the four Catapult alumni who received grants in the last round:
- INNITIUS, semi-finalist in the Catapult MedTech category in 2021
- Avatar Medical, semi-finalist in the Catapult Digital Health category in 2021
- Time is Brain (Digital Health) and Gate2Brain (Biotech), Catapult semi-finalists in 2022
Innitius is a MedTech start-up based in Bilbao, Spain. It aims to help differentiate between false and real preterm labour threats using their portable diagnostic device, FineBirth. They have been granted EUR 3.8M and will use the funding to complete clinical research, begin manufacturing their products, and move through European regulatory pathway processes.
Exposing the project to top European partners and industry profiles, who test every critical aspect of the company, has certainly been an experience that has helped us to strengthen processes, adapt our development plan, and reduce the risks associated with the project. The programme exposure has also helped us to build an international advisory board that has played a key role in the European Commission’s decision to grant this funding to our company.
Rubén Molina, CEO and Co-founder
Avatar Medical, based in Paris, France, creates patient avatars to help surgeons prepare for surgery. Their technology instantly makes interactive 3D representations of patients based on standard medical images in an immersive virtual reality. They will use their new funding to accelerate the development of their 3D solution for shorter, safer, and less invasive surgeries.
The pitch course with Colin Bennet will help me for my entire career. As the EIC exercise was also a short zoom pitch, we were in very similar conditions as with the EIT Health exercise.
Elodie Brient-Litzler, Founder and COO
Time is Brain is a digital health start-up based in Barcelona, Spain, that aims to help stroke patients with their BraiN20(R) solution. The start-up received EUR 2.5M from the EIC Accelerator programme and will use the funding to validate the BraiN20, start industrialising, obtain the CE Mark, and commercialise their product.
I would like to thank the EIT Health Catapult programme for its support and mentoring. Thanks to the team and especially to the coaches and mentors. I would also like to thank Eric Garnier and Colin Bennet. Their teaching was extremely valuable for preparing for the EIC Accelerator programme interview. I am grateful for their dedication and commitment.
Alicia Martínez, Founder and CEO
Gate2Brain is a biotech start-up based in Barcelona, Spain, that uses its peptide-based patented solution to improve the transport of drugs to the brain. They have been granted EUR 2.5M and will use the funding to navigate the pre-clinical regulations for their flagship product, G2B-002.
Our virtual coffees with Dirk Groenenwegen were an excellent brainstorm exercise about how Gate2Brain could achieve a broader impact and approach pharma companies to use our technology with their candidates of different modalities.
Meritxell Teixidó, Founder and CEO
Their Catapult mentor Dirk Groenenwegen added: “As Gate2Brain’s mentor under the EIT Health Catapult programme, it was an honour and a pleasure to guide the management of Gate2 Brain with their business case and perfect their pitch.”
Share this page
